Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...
The ‘triple G’ experimental drug also led to greater reductions in A1C. Drugmaker Lilly is expected to apply for FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results